Skip to main content
OpenTrials
Recruiting

NCT Number: NCT07702123

Efficacy of Physical Activity Program in Metabolic-syndrome Females With Behcet Disease

metabolci syndrom is highly prevalent in behcet disorder females. usually physical activity is recommended to solve this problem

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Metabolic Syndrome Behcet Disease Behcet Syndrome Cardiovascular Diseases Congenital, Hereditary, and Neonatal Diseases and Abnormalities Eye Diseases Genetic Diseases, Inborn Glucose Metabolism Disorders Hereditary Autoinflammatory Diseases Hyperinsulinism Insulin Resistance Metabolic Diseases Mouth Diseases Nutritional and Metabolic Diseases Panuveitis Skin Diseases Skin Diseases, Genetic Skin Diseases, Vascular Skin and Connective Tissue Diseases Stomatognathic Diseases Uveal Diseases Uveitis Uveitis, Anterior Vascular Diseases Vasculitis

Age range

40 year–50 year

Sex eligibility

Female

Study type

Interventional

Phase

Not applicable

Primary location

About this study

metabolci syndrom-fenales with behcet disorder (n=40) were assigned to group I or group II. Group I will perform treadmill walk for 40 minutes. group II will act as waitlist. the group will contian 20 females

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • females with metabolci syndrome
  • females with behcet disorder

Exclusion criteria

  • psychatric diseases women
  • mental diseased women

Treatment and study plan

treadmill walking

Behavioral

metabolci syndrom-females with behcet disorder assigned to group I (n=20) will perform treadmill walk for 40 minutes, thrice weekly, for 12 weeks

Primary outcomes

  1. high density lipoprotin

    Time frame: it will be asessed after 12 weeks

    it is a lipid profile component

Secondary outcomes

  1. triglycrides

    Time frame: It will be assessed after 12 weeks

    it is a lipid profile component

  2. body mass index

    Time frame: It will be assessed after 12 weeks

    it will be assessed on empty stomach

  3. waist circumfrence

    Time frame: It will be assessed after 12 weeks

    it will be assessed with inelsatic tape

  4. fasting blood glucoses

    Time frame: It will be assessed after 12 weeks

    it will be assessed in plasma

  5. systolic blood presssure

    Time frame: It will be assessed after 12 weeks

    it will be assessed at brachial artery

  6. diastolci blood pressure

    Time frame: It will be assessed after 12 weeks

    it will be assessed at brachial artery

  7. subjective vitality scale

    Time frame: It will be assessed after 12 weeks

    A questionaire will assess vitality of subjects

  8. satifaction with life scale

    Time frame: It will be assessed after 12 weeks

    A questionsire will assess satisfaction with life

  9. ptisburg sleep quality index

    Time frame: It will be assessed after 12 weeks

    A questionsire will assess sleep level

  10. fatigue severity scale

    Time frame: It will be assessed after 12 weeks

    A questionsire will assess fatigue level

  11. Behcet disease -related life quality questionaire

    Time frame: It will be assessed after 12 weeks

    A questionsire will assess life quality

  12. ruffier index

    Time frame: It will be assessed after 12 weeks

    it will assess fitness of cardiopulmoanry system

  13. Hamilton anxiety rating scale

    Time frame: It will be assessed after 12 weeks

    A questionsire will assess anxiety

  14. Hamilton depression scale

    Time frame: It will be assessed after 12 weeks

    A questionsire will assess depression

Study contacts

Contact information is provided by the study sponsor or research team.

Ali Ismail, lecturer

CONTACT

[email protected]

+201005154209

Ali mohamed, lecturer

CONTACT

[email protected]

+201033321109

Sponsors and collaborators

Lead sponsor

Cairo University

Other

Registry information

Important dates

Study start
2026
Primary completion
2026
Study completion
2026
First posted
Jul 14, 2026
Registry last updated
Jul 14, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.